57 research outputs found
Once-daily tiotropium Respimat® add-on to at least medium- to high-dose ICS, with or without LABA, improves lung function in patients with symptomatic asthma, independent of allergic status
Intuition & Calibration
The practice of appealing to intuitive judgments concerning esoteric cases, long standard in analytic philosophy, has recently fallen on hard times. Various recent empirical results have suggested that philosophers are not currently able to distinguish good intuitions from bad. This paper evaluates one possible type of approach to this problematic methodological situation: calibration. Both critiquing and building on an argument from Robert Cummins, the paper explores what possible avenues may exist for the calibration of philosophical intuitions. It is argued that no good options are currently available, but leaves open the real possibility of such a calibration in the future.</jats:p
P231 Once-daily Tiotropium Respimat(R): Safety And Tolerability Results From Five Phase Iii Trials In Adults With Symptomatic Asthma
Once-daily tiotropium Respimat® add-on to at least medium- to high-dose ICS, with or without LABA, improves lung function in patients with symptomatic asthma, independent of allergic status
P150 Once-daily tiotropium Respimat® reduces risk of severe asthma exacerbation and asthma worsening in symptomatic asthma, independent of allergic and inflammatory status
Search for Chromosome Instability in Lymphocytes with Germ-Line Mutations in DNA Mismatch Repair Genes
P156 Efficacy, safety and tolerability of once-daily tiotropium respimat® add-on therapy in children with moderate symptomatic asthma
Tiotropium Respimat® add-on therapy to inhaled corticosteroids (ICS) + long-acting β2-agonists (LABAs) in patients with symptomatic severe asthma: efficacy by level of airway obstruction
- …
